Albumin-Binding Moieties Tune the Pharmacokinetics and Tumor Uptake of 177Lu-Labeled GRPR Radioligands
Karim Obeid, Esther Olaniran Håkansson, Ekaterina Bezverkhniaia, Bobo Skillinghaug et autres
0 citationsACS Medicinal Chemistry Letters
Ekaterina Bezverkhniaia
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
36Publications signalées
197Citations signalées
4Affiliations récentes
Institutions déclarées
Domaines associés
Radiopharmaceutical Chemistry and ApplicationsProstate Cancer Treatment and ResearchMonoclonal and Polyclonal Antibodies ResearchPeptidase Inhibition and AnalysisMedical Imaging Techniques and Applications
Publications récentes
Experimental radiotherapy with the gastrin-releasing peptide receptor (GRPR) antagonist [177Lu]Lu-AU-SAR-M1 in a prostate cancer murine model using reduced-frequency dosing
Karim Obeid, Mark Konijnenberg, Ekaterina Bezverkhniaia, Θεοδοσία Μάινα et autres
0 citationsBiomedicine & Pharmacotherapy
PSMA-Targeting SPECT Tracer with Positively Charged Mercaptoacetyl-Based Chelator: Preclinical Evaluation and Exploratory Clinical Study
Ekaterina Bezverkhniaia, Athanasios Bitzios, Panagiotis Kanellopoulos, Ivan V. Zelepukin et autres
0 citationsChemical & Biomedical Imaging
Improving GRPR-targeting peptides for radiotheranostics application: insights from chelator modifications and α-methyl-L tryptophan substitution
Karim Obeid, Ekaterina Bezverkhniaia, Vladimir Tolmachev, Anna Orlova et autres
2 citationsEJNMMI Radiopharmacy and Chemistry
A New PSMA-targeted Radiopharmaceutical for Single-Photon Emission Computed Tomography
A. А. Medvedeva, В. И. Чернов, M. S. Larkina, R. V. Zeltchan et autres
0 citationsVoprosy Onkologii
Evaluation of [177Lu]Lu-radiolabelled bombesin antagonists as potential candidates for GRPR-targeting therapeutic use in prostate cancer
Karim Obeid, Panagiotis Kanellopoulos, Ekaterina Bezverkhniaia, Mark Konijnenberg et autres
0 citationsNuclear Medicine and Biology
Head-to-head evaluation of new generation GRPR-targeting theranostics labelled with Lu-177 / Ga-68
Panagiotis Kanellopoulos, Karim Obeid, Ekaterina Bezverkhniaia, Athanasios Bitzios et autres
0 citationsNuclear Medicine and Biology
A new SPECT agent for PSMA visualization, [99mTc]Tc-BQ0413: preclinical evaluation and preliminary results of Phase I clinical study
Ekaterina Bezverkhniaia, Anna Orlova, Panagiotis Kanellopoulos, А. A. Medvedeva et autres
0 citationsNuclear Medicine and Biology
Feasibility of imaging CEACAM5 expressing xenografts using radiolabeled affibody molecules
Vladimir Tolmachev, Eleftherios Papalanis, Johan Nilvebrant, Maryam Oroujeni et autres
0 citationsNuclear Medicine and Biology
Linker modifications in radiolabeled RM26-based antagonists to gastrin-releasing peptide receptor (GRPR) improved tracers’ pharmacokinetics
Ekaterina Bezverkhniaia, Ayman Abouzayed, Panagiotis Kanellopoulos, Vladimir Tolmachev et autres
1 citationEuropean Journal of Pharmaceutical Sciences
Reduction of Negative Charge in Mercaptoacetyl-Based Chelators Influences the Biodistribution of Prostate-Specific Membrane Antigen-Targeting Pseudopeptides Labeled with Technetium-99m
Ekaterina Bezverkhniaia, Panagiotis Kanellopoulos, Ulrika Rosenström, Vladimir Tolmachev et autres
1 citationACS Pharmacology & Translational Science
Preclinical Positron Emission Tomography Imaging of B7–H3 Expression Using Affibody Molecules Labeled with Gallium-68
Vladimir Tolmachev, Ekaterina Bezverkhniaia, Eleftherios Papalanis, Aliyu Muhammad et autres
3 citationsACS Pharmacology & Translational Science
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.